Noliprel (Perindopril Tert-Butylamine, Indapamide)

Perindopril tert‑butylamine and indapamide, the active ingredients in Noliprel, are an ACE inhibitor and thiazide‑like diuretic presented as an oral tablet for oral use. The combination is indicated for the management of hypertension in adult patients through effective blood pressure reduction and improved cardiovascular outcomes.

GNH USA supplies Noliprel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with reliable logistics, quality assurance and regulatory support for global distribution, ensuring timely delivery and compliance with local health authority requirements.

Noliprel, a combined ACE inhibitor and thiazide‑like diuretic, is used in the treatment of hypertension and related blood‑pressure disorders. - Essential hypertension: lowers systolic and diastolic pressure to target levels. - High blood pressure: provides sustained blood‑pressure control when monotherapy is insufficient. - Hypertension with fluid retention: adds diuretic effect to reduce edema while controlling pressure.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after the first dose. - Headache: mild to moderate intensity. - Fatigue or general weakness. - Increased urination due to diuretic action. - Electrolyte disturbances such as low potassium.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure causing fainting. - Acute renal impairment: sudden decrease in kidney function. - Hyperkalemia: elevated potassium levels, potentially dangerous. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following precautions: - Blood pressure monitoring: ensure target levels are achieved without excessive drop. - Renal function assessment: evaluate serum creatinine and eGFR periodically. - Electrolyte balance: monitor sodium and potassium, especially when combined with other diuretics. - Pregnancy safety: avoid use unless benefits outweigh potential risks, as data are limited. - Concomitant potassium‑sparing agents: use with caution to prevent hyperkalemia. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Noliprel may interact with several medicines; awareness of the interaction level helps guide management. Major Interactions (Avoid): - ACE inhibitor with ARB or aliskiren: increased risk of renal dysfunction and hyperkalemia. - Potassium supplements or potassium‑sparing diuretics: may cause dangerous hyperkalemia. - NSAIDs (e.g., ibuprofen, naproxen): can blunt antihypertensive effect and impair renal function. Moderate Interactions (Monitor Closely): - Lithium: may increase lithium levels, requiring serum monitoring. - Other antihypertensives (beta‑blockers, calcium channel blockers): may enhance hypotensive effect. - Diuretics: additive diuretic effect may lead to electrolyte loss; monitor electrolytes.